Dyslipidemia: Everything You Should Know
Note sull'episodio
Dyslipidemia – It has an outsized presence in correctional health settings and can be tough to manage for those patients. Fortunately for providers across all settings, managing dyslipidemia is becoming more streamlined with a new set of guidelines from the American College of Cardiology/American Heart Association.
Chris is here to break down these 2026 dyslipidemia guidelines, highlighting updated risk assessment tools, cholesterol targets, and evidence-based therapies while offering practical guidance tailored to correctional healthcare.
To see Chris' handy dyslipedmia pocket guide, sign up for an account at opticsclinical.com.
Before that, Chris brings us up to speed with medication news
Baxfendy- A brand new aldosterone synthase inhibitor
Ozempic- Oral tablets and the “retirement” of Rybelsus
Hepcludex- Accelerated approval for the only Hep D drug in the US
Orphines- Another synthetic opioid to look out for
And to finish things out, we look at the amazing story of statins and their unlikely origin.
Link to the full show notes with references for further reading.
Sponsor Links:
Music in this Episode:
The Retro Synth by Art Haiz
Vitals & Headlines (Suno AI)
Breezy Thoughts (Suno AI)
Trivia Time Ticker (Suno AI)